NASDAQ · NXPLW

NextPlat Corp.

$0.00 -$0.00 (-38.46%) 1D

Key Metrics

$6.23K
Market cap
P/E · TTM
Revenue · TTM
−$10.24M
Net income
EPS · TTM $-3.94
Dividend yield
Free cash flow −$6.70M
Beta · 1Y -0.01
EBITDA · TTM −$9.83M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 2
    From its Feb 2 high, the share price fell 98%.

    Peak close $0.11 on Feb 2; trough close $0.00 on Jun 2. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -98%
  • May 1
    The stock moved +73.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 1
  • Apr 13
    The stock moved +204.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value−$9.85M
Shares outstanding
52-wk range$0.00 – $0.21
Avg volume · 20D7.1K
Net cash $9.86M
Book value / share$6.35
IndustryTelephone Communications (No Radiotelephone)
ExchangeNASDAQ
About NextPlat Corp.
IPO dateMay 28, 2021
Employees180

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -47.4% · -154.9%

Financial Health

Current ratio2.56
Quick ratio2.12
Debt / equity0.07
Debt / EBITDA -0.12
Net cash $9.86M
Working capital$14.17M

Cash Flow · TTM

Operating CF −$6.65M
Capex −$49.00K
Free cash flow −$6.70M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings